ESMO Media Releases

The European Society for Medical Oncology has announced the winners of the ESMO awards 2020.

Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today by ESMO

The science weekend of the ESMO Congress 2020 will be held as a virtual meeting between 19 and 21 September.

In Annals of Oncology, ESMO’s comprehensive set of recommendations address open questions on how to manage cancer care in the COVID-19 era

The ESMO Congress 2020 will be held as a virtual meeting, with the programme delivered over two weekends:

• Science weekend on 19-21 September
• Educational weekend on 16-18 October

Artificial intelligence (AI) holds promise for enabling earlier detection of pancreatic cancer, which is crucial to saving lives. The potential of AI is showcased in a study to be presented at the ESMO World Congress on Gastrointestinal Cancer, 1-4 July 2020.

The ESMO World Congress on Gastrointestinal Cancer 2020 will be held as a virtual meeting, on 1-4 July.

ESMO, the leading professional organisation for medical oncology, has today announced the appointment of Professor George Pentheroudakis MD PhD as its new Chief Medical Officer (CMO).

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment.

Cancer-related fatigue is a prevalent and potentially persistent issue among breast cancer survivors, which can prevent them from returning to their previous life well after treatment ends and they are declared free of disease. 

The 2020 ESMO Breast Cancer Congress will be held as a virtual meeting, on 23-24 May.

Death rates from prostate cancer are predicted to fall in 2020 in the EU, according to new research published in the journal Annals of Oncology.